Case Challenge

Management of a 38-Year-Old HBeAg-Positive Asian American Man Seeking First-Line Treatment for Hepatitis B

Source: Choosing First-Line Therapy in Chronic Hepatitis B

Management of a 38-Year-Old HBeAg-Positive Asian American Man Seeking First-Line Treatment for Hepatitis B


Faculty:

  • Norah Terrault, MD, MPH

CME CREDIT INFORMATION

Release Date: 05/25/07

Expiration Date: 05/24/08


Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe criteria for selecting optimal first-line therapy in HBeAg-positive patients
  • Discuss strategies for managing resistance in HBeAg-positive patients
  • Recount data regarding the optimal duration of treatment and posttreatment monitoring strategies in HBeAg-positive patients

Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.